ArticlePatient preference and adherence2018

High treatment adherence, satisfaction, motivation, and health-related quality of life with fingolimod in patients with relapsing-remitting multiple sclerosis - results from a 24-month, multicenter, open-label Danish study.

Karen Schreiber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.